Quality-of-care indicators for oncology management : an analysis of Asia-Pacific healthcare and oncology indicators

Article indépendant

KANESVARAN, R. | WONG, E. Y. T. | KEAM, B. | PRASONGSOOK, N. | MALHOTRA, H. | BLAY, J.-Y.

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures of healthcare quality that help measure or quantify healthcare processes, outcomes, and organizational systems to help promote and provide equitable high-quality healthcare. A detailed list of quality indicators in medical, surgical, and palliative oncology was identified from literature reviews. This study, which was commissioned by the ESMO Asia Pacific Public Policy Committee, aims to report on the performance of healthcare and oncology quality indicators across 47 countries in the Asia-Pacific region.

http://dx.doi.org/10.1016/j.esmoop.2025.104293

Voir la revue «ESMO open, 10»

Autres numéros de la revue «ESMO open»

Consulter en ligne

Suggestions

Du même auteur

Quality-of-care indicators for oncology manag...

Article | KANESVARAN, R. | ESMO open | n°3 | vol.10

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures ...

Quality-of-care indicators for oncology manag...

Article indépendant | KANESVARAN, R. | ESMO open | n°3 | vol.10

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures ...

Globalization of clinical trials in oncology ...

Article | IZARN, F. | ESMO open | n°1 | vol.10

BACKGROUND: Over the past two decades, the globalization of oncology clinical trials has expanded, yet significant disparities persist across countries. This study aimed to evaluate these geographical inequalities, the evolution o...

De la même série

Quality-of-care indicators for oncology manag...

Article indépendant | KANESVARAN, R. | ESMO open | n°3 | vol.10

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures ...

Effects of a communication training for oncol...

Article indépendant | HARNISCHFEGER, N. | ESMO open | n°6 | vol.7

INTRODUCTION: In advanced cancer care, early communication about palliative care (PC) and end-of-life (EoL)-related issues is recommended, but is often impeded by physicians' communication insecurities. We investigated the effect ...

ESMO designated centres of integrated oncolog...

Article indépendant | KREYE, G. | ESMO open | n°6 | vol.7

BACKGROUND: The European Society for Medical Oncology (ESMO) Designated Centres (DCs) of Integrated Oncology and Palliative Care is an incentive programme established in 2003 aiming to improve the integration of oncology and palli...

Role and responsibility of oncologists in ass...

Article indépendant | SCHILDMANN, Jan | ESMO open | n°6 | vol.6

BACKGROUND: Physician-assisted suicide (PAS) is a controversial practice and regulatory frameworks differ regarding assigned physicians' roles. This study explores clinical experience and views of German oncologists concerning eth...

Late decisions about treatment limitation in ...

Article indépendant | MEHLIS, Katja | ESMO open | n°5 | vol.5

Background: Decisions to limit treatment (DLTs) are important to protect patients from overtreatment but constitute one of the most ethically challenging situations in oncology practice. In the Ethics Policy for Advance Care Plann...

Chargement des enrichissements...